Trial to Assess Long-term Lacosamide (LCM) Monotherapy Use and Safety of LCM Monotherapy and Adjunctive Therapy for Partial-onset Seizures

Completed · Phase 3

Conditions studied: Epilepsy

In brief

This open-label extension trial will assess the long-term use of Lacosamide monotherapy and safety of Lacosamide monotherapy and adjunctive therapy in subjects with partial-onset seizures who were previously enrolled in the conversion to monotherapy trial (SP902).

Key facts

Study ID

NCT00530855

Run by

UCB Pharma

People needed

322

Starts

2008-02-01

Expected to finish

2014-12-01

Last updated by the study team

2018-07-18

Who can join

Age: 16 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Subject has entered the Maintenance Phase of the double-blind trial, SP902, (ie, has taken at least 1 dose of SP902 Maintenance Phase trial medication) and either completed SP902 or met an exit criterion in SP902; subject is allowed up to 2 concomitant Antiepileptic Drugs (AEDs)

You may not qualify if…

• Subject meets the withdrawal criteria (excluding exit criteria) for the SP902 trial, or is experiencing an ongoing Serious Adverse Event (SAE)

Where it is running

• 010 — Birmingham, Alabama, United States
• 042 — Northport, Alabama, United States
• 009 — Phoenix, Arizona, United States
• 014 — Phoenix, Arizona, United States
• 151 — Phoenix, Arizona, United States
• 103 — Tucson, Arizona, United States
• 102 — Jonesboro, Arkansas, United States
• 007 — Little Rock, Arkansas, United States
• 086 — Little Rock, Arkansas, United States
• 120 — La Habra, California, United States
• 059 — Los Angeles, California, United States
• 021 — Santa Monica, California, United States
• 107 — Torrance, California, United States
• 060 — Aurora, Colorado, United States
• 025 — Fairfield, Connecticut, United States
• 094 — Doral, Florida, United States
• 108 — Gainesville, Florida, United States
• 123 — Miami, Florida, United States
• 132 — Miami, Florida, United States
• 077 — Orlando, Florida, United States
• 049 — Panama City, Florida, United States
• 129 — Port Charlotte, Florida, United States
• 050 — Sarasota, Florida, United States
• 004 — Tallahassee, Florida, United States
• 048 — Alabaster, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.